Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Dow
McKesson
Chinese Patent Office
Merck
Harvard Business School
Boehringer Ingelheim
UBS
AstraZeneca

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050627

« Back to Dashboard

NDA 050627 describes RIFADIN, which is a drug marketed by Sanofi Aventis Us and is included in three NDAs. It is available from one supplier. Additional details are available on the RIFADIN profile page.

The generic ingredient in RIFADIN is rifampin. There are nine drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the rifampin profile page.
Summary for 050627
Tradename:RIFADIN
Applicant:Sanofi Aventis Us
Ingredient:rifampin
Patents:0
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 050627
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIFADIN rifampin INJECTABLE;INJECTION 050627 NDA Sanofi-Aventis U.S. LLC 0068-0597 N 0068-0597-01
RIFADIN rifampin INJECTABLE;INJECTION 050627 NDA Sanofi-Aventis U.S. LLC 0068-0599 N 0068-0599-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength600MG/VIAL
Approval Date:May 25, 1989TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
McKinsey
Federal Trade Commission
Daiichi Sankyo
Johnson and Johnson
AstraZeneca
Chubb
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.